secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001213900-23-047184
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake Immunotherapeutics announces 2023 AGM results; directors elected, auditor ratified
--------------------------------------------------------------------------------

- Dr. Kara Lassen elected as Class I director with 37,996,564 votes for, 93,222 withheld.
- Spike Loy elected as Class I director with 37,728,807 votes for, 360,979 withheld.
- Ratification of Baker Tilly US, LLP as independent auditor passed with 41,585,151 votes for, 366 against.
- Broker non-votes totaled 3,496,781 on director elections; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390023047184/0001213900-23-047184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390023047184/ea179949-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-047184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer